Obesity Surgery

, Volume 28, Issue 6, pp 1806–1808 | Cite as

Improvement of Body Composition and Quality of Life Following Intragastric Balloon

  • Silvia Mansur Reimão
  • Maria Elizabeth Rossi da Silva
  • Gabriel Cairo Nunes
  • Luiz Henrique Mazzonetto Mestieri
  • Rosa Ferreira dos Santos
  • Eduardo Guimarães Hourneaux de Moura
Brief Communication



The aim is to evaluate the effects of IGB in overweight or class I obese patients, by analyzing body composition and quality of life (QOL).


Prospective study including patients with BMI 27–34.9 kg/m2.body composition analysis (BCA) was performed before IGB implantation and its removal, after 6 months of treatment. QOL was assessed by the Short Form 36 (SF-36) Health Survey at baseline and after treatment.


Forty patients were included in this study, but four were excluded. The total weight decreased by 12.29 kg after 6 months of use of IGB, which corresponds to loss of 13.69% of the total weight. There was a significant reduction in body fat mass and fat area. QOL improved in all eight sections analyzed (p < 0.001 to 0.041): functional capacity, physical aspects, pain, general health status, vitality, social aspects, emotional aspects, and mental health.


IGB induces not only weight loss but changes in body composition through the reduction of body fat mass and fat area. Furthermore, it improves QOL.


Gastric balloon Quality of life Body composition Electric impedance Weight loss Bariatric medicine 


Compliance with Ethical Standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Conflict of Interest

The authors declare that they have no conflict of interest.

Informed Consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    Global Health Observatory (GHO) data: Overweight and obesity. Accessed 01 Jun 2016, 2016.
  2. 2.
    Crea N, Pata G, Della Casa D, et al. Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg. 2009;19(8):1084–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Gottig S, Daskalakis M, Weiner S, et al. Analysis of safety and efficacy of intragastric balloon in extremely obese patients. Obes Surg. 2009;19(6):677–83.CrossRefPubMedGoogle Scholar
  4. 4.
    Mathus-Vliegen EM. Intragastric balloon treatment for obesity: what does it really offer? Dig Dis. 2008;26(1):40–4.CrossRefPubMedGoogle Scholar
  5. 5.
    Dargent J. Novel endoscopic management of obesity. Clin Endosc. 2016;49(1):30–6.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Mathus-Vliegen EM, Eichenberger RI. Fasting and meal-suppressed ghrelin levels before and after intragastric balloons and balloon-induced weight loss. Obes Surg. 2014;24(1):85–94.CrossRefPubMedGoogle Scholar
  7. 7.
    Wadden TA, Webb VL, Moran CH, et al. Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy. Circulation. 2012;125(9):1157–70.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Abu Dayyeh BK, Kumar N, Edmundowicz SA, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82(3):425–438.e425.CrossRefPubMedGoogle Scholar
  9. 9.
    Mui WL, Ng EK, Tsung BY, et al. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg. 2010;20(8):1128–32.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Silvia Mansur Reimão
    • 1
  • Maria Elizabeth Rossi da Silva
    • 2
  • Gabriel Cairo Nunes
    • 1
  • Luiz Henrique Mazzonetto Mestieri
    • 1
  • Rosa Ferreira dos Santos
    • 2
  • Eduardo Guimarães Hourneaux de Moura
    • 1
  1. 1.Gastrointestinal Endoscopy UnitHospital das Clínicas da Faculdade de Medicina da Universidade de São PauloSão PauloBrazil
  2. 2.Diabetes Unit, Endocrinology and Metabology ServiceHospital das Clínicas da Faculdade de Medicina da Universidade de São PauloSão PauloBrazil

Personalised recommendations